Posted by Hugo Ottolenghi
October 11th, 2009
The Web has erupted with news, opinion and practical guidance on the new FTC rules that apply to disclosures on blogger freebies. As a public service, NutriSupLaw offers a sampling of the best of initial analysis.
Posted by Hugo Ottolenghi
May 27th, 2009
In the days following the FDA warning on the dangers of taking Hydroxycut and the manufacturer’s recall, the reaction has been more sliced than divided. There were the oft-seen reactions: NaturalNews headlined its commentary, “FDA Floats Hydroxycut Scare to Discredit Yet Another Supplement Company.” The personal injury law firm of Onder Shelton O’Leary & Peterson [...]
Posted by Hugo Ottolenghi
May 6th, 2009
The Food & Drug Administration issued on May 1 a consumer warning to stop using Hydroxycut, the heavily marketed weight-loss product. The agency said that “some Hydroxycut products are associated with a number of serious liver injuries” and announced that the maker was recalling all products.
Did the FDA properly react? The warning cited 23 serious [...]
Posted by Joel Rothman
May 1st, 2009
The FDA has just announced a massive recall of the popular weight loss supplement, Hydroxycut.
According to the FDA press release dated today, FDA has received 23 reports of serious health problems ranging from jaundice and elevated liver enzymes, an indicator of potential liver injury, to liver damage requiring liver transplant. One death due to liver [...]
Posted by Vincent Annunziata
February 11th, 2009
The National Advertising Division (NAD) of the Council of Better Business Bureaus (BBB) is referring advertising for the dietary supplement Colotox, from Phoenix-based Central Coast Nutraceuticals Inc., to the FDA and FTC for review. Under its National Advertising Review Council (NARC) program, NAD had asked the company for substantiation of certain claims for its product, [...]
Posted by Hugo Ottolenghi
February 10th, 2009
What do sibutramine, rimonabant, phenytoin and phenolphthalein have in common? You can find them spread among the 69 brands of weight-loss pills identified by the FDA. The weight-loss segment of the industry will likely see even more scrutiny of its manufacturing practices now that the FDA has targeted products that it considers harmful or [...]